Overview

Topical Steroid Treatment For Dry Eye

Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
0
Participant gender:
All
Summary
Many patients refer to an oculoplastic or corneal clinic examination due to dry eye symptoms. epidemiologic studies estimate that as many as 15% of the population over 60 years suffer from dry eye. the disease can be treated both topically through several drugs or through mechanical closure of the lacrimal drainage system. in the past decade a few studies demonstrated the efficacy of anti inflammatory treatment on dry eye disease due to the inflammatory process that occurs in it. this treatment rises goblet cell counts but in the meantime elevates the intra ocular pressure and elevates the risk for infections. steroids that cause a lower increase in intraocular pressure have not been thoroughly evaluated in dry eye disease. we with to subjectively and objectively evaluate an FDA approved topical steroidal drug in the treatment of dry eye.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Loteprednol Etabonate
Criteria
Inclusion Criteria:

- referral for ophthalmic examination due to dry eye symptoms

- ability to sign a concent form

Exclusion Criteria:

- former corneal, eyelid or lacrimal gland operations

- former orbital chemotherapy or irradiation treatment